DIA Korea: Medical Turmoil, Global Factors Blunt Korea’s Trial Edge

‘Time To Act’

 
• By Jung Won Shin
  
DIA Korea Meeting 2025
Clinical Trial Impact From Korean, Global Macro-Environmental Changes Discussed

More from South Korea

More from R&D